A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension

National Taiwan University Hospital, Taipei

National Cheng Kung University Hospital, Tainan City

Gottsegen György Országos Kardiológiai Intézet, Felnőtt kardiológiai osztály, Budapest

UZ Gent, Ghent

Univerzitetska Dečja Klinika, Belgrade

Institut Za Zdravstvenu Zastitu Majke I Deteta Srbije Dr Vukan Cupic, Belgrade

Chu Hopital Des Enfants, Toulouse

CHU Arnaud de Villeneuve, Montpellier

Municipal Enterprise Of The Dnipropetrovsk Regional Council, Dnipro

Institut Jantung Negara (National Heart Institute), Kuala Lumpur

University of Iowa Hospital, Iowa City

Sheba Medical Center, Ramat Gan

Municipal Institution Of The Zaporizhzhya Regional Council, Zaporizhzhya

Universitätsklinikum Freiburg Zentrum, Freiburg im Breisgau

Hôpital Necker - Enfants Malades, Paris

Lviv Regional Clinical Hospital, Lviv

Children'S Hospital Cardiac Care Center University Of Colorado, Aurora

Sarawak General Hospital, Kota Samarahan

Seattle Children's Hospital, Seattle

Beijing Anzhen Hospital, Beijing

Moscow Scientific Research Institute For Pediatrics And Childrens Surgery Of Rosmedtechnologies, Moscow

Saint Petersburg State Pediatric Medical University, Saint Petersburg

Federal State Budgetary Institution, Saint Petersburg

Shanghai Childrens Medical Center, Shanghai

State Institution Republican Scientific And Practical Center For Pediatric Surgery, Minsk

Health Institution 4Th City Children'S Clinical Hospital, Minsk

Kazan State Medical University, Kazan'

Samara Regional Clinical Cardiological Dispensary, Samara

Federal State Budget Scientific Institution, Kemerovo

Centre Hospitalier Sainte Justine, Montreal

Schneider Children's Medical Center, Petach Tikvah

Wojewodzki Szpital Specjalistyczny We Wroclawiu, Wroclaw

State Institution Of The Ministry Of Health Of Ukraine, Kiev

Great Ormond Street Hospital, London